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Background: This study investigates the potential volume and outcome association of coronary heart disease (CHD) patients who 
have undergone percutaneous coronary intervention (PCI) using a large and representative sample. 
Methods: We used a National Health Insurance Service-Cohort Sample Database from 2002 to 2013 released by the Korean Na-
tional Health Insurance Service. A total of 8,908 subjects were analyzed. The primary analysis was based on Cox proportional haz-
ards models to examine our hypothesis. 
Results: After adjusting for confounders, the hazard ratio of thirty-day and 1-year mortality in hospitals with a low volume of CHD 
patients with PCI was 2.8 and 2.2 times higher (p= 0.00) compared to hospitals with a high volume of CHD patients with PCI, respec-
tively. Thirty-day and 1-year mortality of CHD patients with PCI in low-volume hospitals admitted through the emergency room 
were 3.101 (p= 0.00) and 2.8 times higher (p= 0.01) than those in high-volume hospitals, respectively. Only 30-day mortality in low-
volume hospitals of angina pectoris and myocardial infarction patients with PCI was 5.3 and 2.4 times those in high-volume hospi-
tals with PCI, respectively. 
Conclusion: Mortality was significantly lower when PCI was performed in a high-volume hospital than in a low-volume hospital. 
Among patients admitted through the emergency room and diagnosed with angina pectoris, total PCI volume (low vs. high) was 
associated with significantly greater cardiac mortality risk of CHD patients. Thus, There is a need for better strategic approaches from 
both clinical and health policy standpoints for treatment of CHD patients.
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INTRODUCTION
There is considerable evidence to conclude that high-volume 
hospitals have lower mortality rates compared with low-volume 
hospitals following complex surgical procedures [1,2]. Since the 
first volume-outcome relation was reported by Luft et al. [3] in 
1979 in cardiology, the association between a hospital’s percutane-
ous coronary intervention (PCI) volume and in-hospital mortality 
has been extensively investigated [1,3,4]. Furthermore, many earli-
er studies demonstrated that patients with acute myocardial in-
farction (AMI) at hospitals performing many primary PCI proce-
dures had lower mortality rates than those at hospitals performing 
less primary PCI procedures [5], and an inverse volume-outcome 
relationship for PCI was reported in many studies [6,7].
The introduction of PCI using a balloon catheter by Gruentzig 
et al. [8] in 1977 revolutionized the treatment of coronary artery 
disease. Coronary restenosis, a common complication in the early 
years, was reduced with the implantation of coronary stents used 
since 1986 [9], a procedure that became standard. In 2001, initially 
employed uncoated stents were replaced with drug-eluting stents, 
first eluting sirolimus [10], followed by paclitaxel [11], and subse-
quently by other drugs [12,13] which, though they failed to abolish 
restenosis and the need for re-intervention, have made these oc-
currences less frequent.
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Primary PCI is now established as a first-line therapeutic strate-
gy for patients with AMI. Several reports from the United States 
and France regarding patients undergoing primary PCI have 
demonstrated an inverse relationship between the hospital volume 
of primary PCI and in-hospital mortality [5,14].
There is growing interest in the use of procedure volume as a 
means of identifying hospital quality of care [15]. Based on this ev-
idence, the updated American College of Cardiology/American 
Heart Association/Society for Cardiovascular Angioplasty and 
Intervention (ACC/AHA/SCAI) PCI clinical practice guidelines 
recommend that the minimum annual institutional volume re-
quirement for hospitals offering PCI for ST-segment elevation 
myocardial infarction (STEMI) be at least 400 elective and 36 pri-
mary PCI procedures [16]. In addition, matching current ACC/
AHA PCI clinical practice guidelines [17], Leapfrog has estab-
lished a minimum institutional volume requirement of 400 cases 
per year for hospitals offering PCI [18]. In contrast, a recent report 
from Tsuchihashi et al. [19] demonstrates that low-volume hospi-
tals and high-volume hospitals have similar in-hospital outcomes 
for primary PCI.
However, detailed data regarding the relationships among hos-
pital primary PCI volume, angiographic results, and in-hospital 
prognosis are still lacking in South Korea. In addition, there have 
been recent changes in PCI practice, with PCI with stent place-
ment being performed more often than balloon angioplasty as 
coronary stent technology has progressed (e.g., drug-eluting 
stents) [20]. We therefore felt it important to reassess this potential 
volume and outcome association using a large and representative 
sample.
METHODS
1. Data sources and study design
This study used a National Health Insurance Service-Cohort 
Sample Database (NHIS-CSD) from 2002 to 2013 released by the 
Korean National Health Insurance Service.
Initial NHIS-CSD cohort members (n=1,025,340) were estab-
lished by stratified random sampling using a systematic sampling 
method to generate a representative sample of the 46,605,433 Ko-
rean residents recorded in 2002. These members were followed up 
on in 2013. The data comprise a nationally representative random 
sample of 1,025,340 individuals, approximately 2.2% of the entire 
2002 population.
The health care utilization claims include information on pre-
scription drugs, medical procedures, and diagnostic codes based 
on the International Classification of Diseases, tenth revision 
(ICD-10), and health care costs. If a member was censored due to 
death or emigration, a new member was recruited among new-
borns of the same calendar year. Detailed methods for establishing 
and ensuring the representativeness of the NHIS-CSD cohort are 
published on the Korean National Health Insurance Service web-
site [21].
In order to analyze the relationship between volume and out-
come association of patients with coronary heart disease (CHD) 
on mortality, we included the ICD-10 code with I20–I25 in our 
data for main diagnosis and cardiac mortality records.
We analyzed a unique database of representative individual 
samples for hospitalized CHD patients with PCI. We linked each 
PCI patient according to license number to a separate licensure 
hospital database that included the calendar years. Linkage be-
tween each CHD patient with PCI and hospital allowed us to 




The number of CHD patients with PCI per year was ranked 
from low to high using SAS Rank function ver. 9.4 (SAS Institute 
Inc., Cary, NC, USA). Thus, the number of CHD patients with PCI 
per year was categorized into four groups: low, middle low, middle 
high, and high.
2) Dependent variables
In this study, our main outcome measures were 30-day and 
1-year mortality. The primary end point for this study was 30-day 
and 1-year mortality after the PCI procedure.
3) Control variables
Individual level (age, sex, household, residential region, patient 
clinical complexity level [PCCL], inpatient type, diagnosis code, 
and type of procedure) and hospital level (proportion of PCI per 
year, organization type, region, beds, doctors, magnetic resonance 
imaging [MRI], and positron emission tomography [PET]) were 
included as variables that could affect mortality in the analysis, 
and all covariate variables were categorical. In order to adjust for 
clinical severity condition in each patient, PCCL, inpatient type, 
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diagnosis code, and type of procedure was used at the individual 
level.
Age groups were divided into five categories: ≤39, 40–49, 50–
59, 60–69, and ≥70 years. Residential regions and region (hospi-
tal level) were categorized as metropolitan (Seoul), urban (Dae-
jeon, Daegu, Busan, Incheon, Gwangju, or Ulsan), or rural (not 
classified as a city). The proportion of PCI per year was divided 
into four categories using SAS Rank function (SAS Institute Inc.): 
low, mid low, mid high, and high.
3. Statistical analysis
The primary analysis was based on Cox proportional hazards 
(PH) models and survival time was calculated as the time between 
30 days or 1 year after the PCI procedure and the date of death. 
The Kaplan-Meier method was used to plot crude survival curves 
according to time following PCI procedure. In Figure 1, we plot a 
survival curve for mortality and a cumulative curve for 30-day or 
1-year mortality. The modeling of long-term outcomes is affected 
by the statistical model applied. Considering that critical illness 
has an effect on outcomes, the Cox PH model, which is the most 
frequently used model, may be accurate because it relies on the as-
sumption that the prognostic factors have constant hazard ratios 
over time.
For all analyses, the criterion for significance was p≤0.05, two-
tailed. All analyses were conducted using the SAS statistical soft-
ware package ver. 9.4 (SAS Institute Inc.).
RESULTS
1. Prevalence of 30-day and 1-year cardiac morality
Of the 8,908 research subjects included in our study, the preva-
lence of 30-day mortality was 2.4% (212 participants) and the 
1-year mortality was 3.9% (349 participants) (Table 1). Of the total 
sample, 2.9% of 30-day mortality and 4.5% of 1-year mortality 
were from hospitals with a low volume of PCI per year, while 1.7% 
of 30-day mortality and 3.1% of 1-year mortality were from hospi-
tals with a high volume of PCI per year (Table 1).
2.  Inverse association between volume and outcome of 
coronary heart disease patients with percutaneous 
coronary intervention
Table 2 adjusted for age, sex, residential region, PCCL, inpatient 
type, diagnosis code, type of surgery, proportion of PCI per year, 
organization type, region, beds, doctors, MRI, and PET. After ad-
justing for all of these confounders, the hazard ratio of 30-day 
mortality in a low-volume CHD with PCI patient hospital was 2.8 
times higher (p= 0.00) compared with those with a high volume 
of CHD patients with PCI. The hazard ratio of 1-year mortality in 
a low-volume CHD with PCI patient hospital was 2.187 times 
higher compared with those in a high-volume CHD with PCI pa-
tient hospital (Table 2).
Table 3 illustrates a subgroup analysis conducted according to 
inpatient type after adjusting for all confounders. Thirty-day mor-
tality in a low-volume CHD patient with PCI hospital admitted 
Figure 1. (A) Adjusted effect of hospital volume on 30-day cardiac mortality. (B) Adjusted effect of hospital volume on 1-year cardiac mortality. 
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Table 1. General characteristics of subjects included for analysis at baseline
Characteristic Total no. (%)
30-day cardiac mortality 1-year cardiac mortality
Yes (%) p-value Yes (%) p-value
# of PCI per year 0.06 0.14
   Low 2,388 (26.8) 69 (2.9) 107 (4.5)
   Mid low 2,292 (25.7) 58 (2.5) 93 (4.1)
   Mid high 2,123 (23.8) 50 (2.4) 83 (3.9)
   High 2,105 (23.6) 35 (1.7) 66 (3.1)
Individual
   Sex 0.00 0.00
      Male 6,024 (67.6) 122 (2.0) 208 (3.5)
      Female 2,884 (32.4) 90 (3.1) 141 (4.9)
   Age (yr) < 0.001 < 0.001
      ≤ 39 987 (11.1) 8 (0.8) 10 (1.0)
      40–49 1,986 (22.3) 16 (0.8) 27 (1.4)
      50–59 2,954 (33.2) 47 (1.6) 75 (2.5)
      60–69 2,376 (26.7) 88 (3.7) 149 (6.3)
      ≥ 70 605 (6.8) 53 (8.8) 88 (14.6)
   Residential region 0.05 0.01
      Metropolitan 1,756 (19.7) 43 (2.5) 62 (3.5)
      Urban 2,275 (25.5) 39 (1.7) 69 (3.0)
      Rural 4,877 (54.8) 130 (2.7)
   Patient clinical complexity level < 0.001 < 0.001
      0 5,193 (58.3) 43 (0.8) 81 (1.6)
      1 2,658 (29.8) 134 (5.0) 188 (7.1)
      ≥ 2 1,057 (11.9) 35 (3.3) 80 (7.6)
   Inpatient type < 0.001 < 0.001
      Emergency room 3,553 (39.9) 147 (4.1) 220 (6.2)
      Outpatient department 5,355 (60.1) 65 (1.2) 129 (2.4)
   Diagnosed code (ischemic heart diseases) < 0.001 < 0.001
      Angina pectoris 4,690 (52.7) 23 (0.5) 77 (1.6)
      Myocardial infarction 2,791 (31.3) 156 (5.6) 209 (7.5)
      Others 1,427 (16.0) 33 (2.3) 63 (4.4)
   Type of procedure < 0.001 < 0.001
      Percutaneous transluminal coronary angioplasty 1,002 (11.3) 42 (4.2) 67 (6.7)
      Percutaneous transcatheter placement of intracoronary stent 7,906 (88.8) 170 (2.2) 282 (3.6)
Hospital
   Proportion of PCI per year 0.24 0.21
      Low 2,473 (27.8) 57 (2.3) 96 (3.9)
      Mid low 2,249 (25.3) 43 (1.9) 74 (3.3)
      Mid high 2,138 (24.0) 54 (2.5) 86 (4.0)
      High 2,048 (23.0) 58 (2.8) 93 (4.5)
   Organization type 0.89 0.56
      Public 76 (0.9) 2 (2.6) 2 (2.6)
      Private 8,832 (99.2) 210 (2.4) 347 (3.9)
   Region 0.00 < 0.001
      Metropolitan 2,455 (27.6) 43 (1.8) 66 (2.7)
      Urban 2,979 (33.4) 62 (2.1) 105 (3.5)
      Rural 3,474 (39.0) 107 (3.1) 178 (5.1)
   Bed 0.00 0.00
      ≤ 499 1,003 (11.3) 20 (2.0) 27 (2.7)
      500–699 1,311 (14.7) 52 (4.0) 77 (5.9)
      700–899 1,359 (15.3) 33 (2.4) 54 (4.0)
      ≥ 900 5,235 (58.8) 107 (2.0) 191 (3.7)
(Continued to the next page)
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Table 1. Continued
Characteristic Total no. (%)
30-day cardiac mortality 1-year cardiac mortality
Yes (%) p-value Yes (%) p-value
   Doctor 0.01 0.00
      ≤ 99 1,673 (18.8) 40 (2.4) 66 (4.0)
      100–199 1,317 (14.8) 40 (3.0) 65 (4.9)
      200–299 1,527 (17.1) 49 (3.2) 81 (5.3)
      ≥ 300 4,391 (49.3) 83 (1.9) 137 (3.1)
   Magnetic resonance imaging 0.68 0.59
      No 7 (0.1) 0 0
      Yes 8,901 (99.9) 212 (2.4) 349 (3.9)
   Positron emission tomography 0.81 0.75
      No 1,226 (13.8) 28 (2.3) 46 (3.8)
      Yes 7,682 (86.2) 184 (2.4) 303 (3.9)
Total 8,908 (100.0) 212 (2.4) 349 (3.9)
PCI, percutaneous coronary intervention.
Table 2. Adjusted effect between # of PCI and cardiac mortality
Variable
30-day cardiac mortality 1-year cardiac mortality
HR SE p-value HR SE p-value
# of PCI per year
   Low 2.8 0.3 0.00 2.2 0.2 0.00
   Mid low 2.3 0.2 0.00 1.8 0.2 0.00
   Mid high 1.9 0.2 0.00 1.5 0.2 0.01
   High 1.0 1.0
Individual
   Sex
      Male 1.2 0.1 0.11 1.5 0.1 < 0.001
      Female 1.0 1.0
   Age (yr)
      ≤ 39 0.2 0.4 < 0.001 0.2 0.3 < 0.001
      40–49 0.3 0.2 < 0.001 0.2 0.2 < 0.001
      50–59 0.6 0.2 0.01 0.4 0.1 < 0.001
      60–69 1.0 0.2 0.95 0.8 0.1 0.04
      ≥ 70 1.0 1.0
   Residential region
      Metropolitan 1.3 0.2 0.19 1.2 0.2 0.23
      Urban   0.7 0.2 0.06 0.8 0.1 0.14
      Rural 1.0 1.0
   Patient clinical complexity level
      0 0.2 0.3 < 0.001 0.3 0.2 < 0.001
      1 0.7 0.2 0.06 0.7 0.2 0.01
      ≥ 2 1.0 1.0
   Inpatient type
      Emergency room 1.4 0.1 0.01 1.2 0.1 0.16
      Outpatient department 1.0 1.0
   Diagnosed code (ischemic heart diseases)
      Angina pectoris 1.0 1.0
      Myocardial infarction 8.8 0.2 < 0.001 3.6 0.1 < 0.001
      Others 2.4 0.2 0.00 1.4 0.2 0.02
   Type of procedure
      Percutaneous transluminal coronary angioplasty 1.5 0.2 0.00 1.5 0.1 0.00
      Percutaneous transcatheter placement of intracoronary stent 1.0 1.0
(Continued to the next page)
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Table 2. Continued
Variable
30-day cardiac mortality 1-year cardiac mortality
HR SE p-value HR SE p-value
Hospital
   Proportion of PCI per year
      Low 0.5 0.2 0.01 0.6 0.2 0.01
      Mid low 0.5 0.2 0.00 0.6 0.2 0.00
      Mid high 0.6 0.2 0.01 0.7 0.1 0.00
      High 1.0 1.0
   Organization type
      Public 0.9 0.7 0.86 0.6 0.7 0.51
      Private 1.0 1.0
   Region
      Metropolitan 0.6 0.2 0.02 0.5 0.2 < 0.001
      Urban 0.8 0.2 0.31 0.7 0.1 0.01
      Rural 1.0 1.0
   Bed
      ≤ 499 0.9 0.4 0.74 0.4 0.3 0.00
      500–699 1.0 0.2 0.95 0.6 0.2 0.02
      700–899 0.6 0.2 0.01 0.5 0.2 < 0.001
      ≥ 900 1.0 1.0
   Doctor
      ≤ 99 0.9 0.3 0.83 1.5 0.2 0.08
      100–199 0.7 0.2 0.18 1.1 0.2 0.55
      200–299 0.9 0.2 0.61 1.1 0.1 0.43
      ≥ 300 1.0 1.0
   Magnetic resonance imaging
      No 0.0 210.6 0.97 0.0 177.5 0.96
      Yes 1.0 1.0
   Positron emission tomography
      No 0.8 0.3 0.43 1.1 0.2 0.78
      Yes 1.0 1.0
PCI, percutaneous coronary intervention; HR, hazard ratio; SE, standard error.
Table 3. Adjusted effect between # of PCI and cardiac mortality by inpatient type
# of PCI per year
Emergency room Outpatient department
30-day cardiac mortality 1-year cardiac mortality 30-day cardiac mortality 1-year cardiac mortality
HR SE p-value HR SE p-value HR SE p-value HR SE p-value
Low 3.1 0.4 0.00 2.8 0.3 0.00 1.7 0.5 0.30 1.2 0.4 0.68
Mid low 2.7 0.3 0.00 2.2 0.2 0.00 1.1 0.4 0.75 0.9 0.3 0.86
Mid high 2.4 0.2 0.00 1.7 0.2 0.00 0.6 0.5 0.36 1.0 0.3 0.99
High 1.0 1.0 1.0 1.0
Adjusted for sex, age, residential region patient clinical complexity level, diagnosed code, type of procedure, proportion of PCI per year, organization type, region bed doctor, magnetic 
resonance imaging, and positron emission tomography.
PCI, percutaneous coronary intervention; HR, hazard ratio; SE, standard error.
through the emergency room was 2.2 times higher (p= 0.00) than 
hospitals with a high volume of CHD patients with PCI. One-year 
mortality in a hospital with a low volume of CHD patients with 
PCI admitted through the emergency room was 2.8 times higher 
(p= 0.00) than hospitals with a high volume of CHD patients with 
PCI.
We then conducted subgroup analysis according to diagnosis 
code after adjusting for all confounders. Thirty-day mortality in a 
hospital with a low volume of angina pectoris patients with PCI 
was 5.3 times higher (p= 0.03) than in a hospital with a high vol-
ume of angina pectoris patients with PCI (Table 4).
Thirty-day mortality in a hospital with a low volume of myocar-
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Table 4. Adjusted effect between # of PCI and cardiac mortality by diagnosed code
# of PCI per year
Angina pectoris Myocardial infarction Others
30-day cardiac mortality 1-year cardiac mortality 30-day cardiac mortality 1-year cardiac mortality 30-day cardiac mortality 1-year cardiac mortality
HR SE p-value HR SE p-value HR SE p-value HR SE p-value HR SE p-value HR SE p-value
Low 5.3 0.7 0.03 1.9 0.5 0.24 2.4 0.3 0.01 2.1 0.3 0.01 2.6 0.8 0.25 1.3 0.5 0.63
Mid low 4.9 0.6 0.00 1.6 0.4 0.23 2.0 0.3 0.01 1.6 0.2 0.03 3.5 0.7 0.07 1.4 0.4 0.38
Mid high 2.9 0.5 0.02 1.4 0.4 0.35 1.6 0.2 0.04 1.4 0.2 0.13 2.8 0.6 0.07 1.6 0.3 0.16
High 1.0 1.0 1.0 1.0 1.0 1.0
Adjusted for sex, age, residential region patient clinical complexity level, inpatient type, type of procedure, proportion of PCI per year, organization type, region bed doctor, magnetic 
resonance imaging, and positron emission tomography.
PCI, percutaneous coronary intervention; HR, hazard ratio; SE, standard error.
dial infarction patients with PCI was 2.4 times higher (p= 0.01) 
than in hospitals with a high volume of myocardial infarction pa-
tients with PCI. One-year mortality in a hospital with a low vol-
ume of myocardial infarction patients with PCI was 2.1 times 
higher (p= 0.01) than in a hospital with a high volume of myocar-
dial infarction patients with PCI.
DISCUSSION
Our study provides insightful evidence regarding the specificity 
of volume and outcome (30-day and/or 1-year mortality) in cur-
rent practice. The significant inverse association between hospital 
volume and 30-day mortality and 1-year mortality after PCI pro-
cedures was evaluated by analyzing the 2002–2013 database of the 
nationally large representative and longitudinal cohort sample in 
Korea.
The major findings of our study are as follows: Korean CHD pa-
tients treated with primary PCI in high-volume hospitals had low-
er cardiac mortality rates than those in low-volume hospitals. 
There was a significant difference between high-volume and low-
volume hospitals in both 30-day and 1-year mortality rates. We 
also found that CHD patients treated at hospitals with relatively 
low annual PCI cases had the highest 30-day and 1-year mortality 
rates, followed by patients treated at middle-low PCI volume hos-
pitals, whereas patients treated at high-PCI volume hospitals had 
the lowest 30-day and 1-year mortality rates.
Additionally, we conducted subgroup analysis according to in-
patient type and diagnosed code. Results of our subgroup analysis 
also showed inverse volume-outcome relationships of CHD pa-
tients with PCI. In particular, there was a substantial difference in 
mortality rate between high-volume and low-volume hospitals for 
patients admitted through the emergency room and diagnosed 
with angina pectoris. After adjusting for patient characteristics 
(sex, age, residential region, PCCL, inpatient type, diagnosis code, 
and type of surgery) and hospital characteristics (proportion of 
PCI per year, organization type, beds, doctors, MRI, and PET), the 
hazard ratio of 30-day and 1-year mortality for patients treated at 
hospitals with low annual PCI cases were 3.1 (p= 0.01) and 2.8 
(p= 0.00) times higher than for patients treated at high-PCI vol-
ume hospitals admitted through the emergency room. In addi-
tion, the hazard ratio of 30-day and 1-year mortality for patients 
treated at hospitals with relatively low annual PCI cases were 
higher than for patients treated at hospitals with a high volume of 
PCI patients with a diagnosis code of angina pectoris and myocar-
dial infarction.
The relationship between the annual hospital volume of prima-
ry PCI and mortality has not been fully investigated in Korea. 
However, several reports from the United States and France dem-
onstrate that low primary PCI-volume hospitals had higher in-
hospital mortality than high-volume hospitals [14,22,23]. In this 
study, our finding is consistent with several previous studies in 
which an inverse relationship between hospital procedure volume 
and adverse outcomes was reported [4,24,25].
According to the guidelines for PCI published by the AHA, 
ACC, and SCAI in 2005, primary PCI for ST-segment elevation 
AMI should be performed in centers with an annual volume of at 
least 400 elective and 36 primary PCI procedures [16], and some 
studies report significant differences in adverse outcomes among 
hospital volume groups with cutoffs other than the 400 annual 
PCI case value [6,26,27]. Although our findings do not lend sup-
port to the minimum annual hospital PCI volumes of 400 cases 
recommended by the ACC/AHA clinical practice guidelines [28], 
our results are in agreement with those [29-31] that show an in-
verse volume-outcome relationship. However, previous studies 
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that show a decrease in mortality with increasing operator volume 
have failed to reach statistical significance because of low sample 
size, large confidence interval, or low procedure-related mortality 
[4,28].
A potential explanation for our subgroup analysis results ac-
cording to inpatient type and diagnosis code is that high-volume 
emergency rooms tend to be located in more urban areas and ac-
commodate more patients with rapid cardiopulmonary resuscita-
tion in progress and these emergency room-admitted patients re-
ceive same-day PCI. Previous study indicates that the strongest 
predictor of same-day PCI use for patients with STEMIs was hos-
pital PCI volume. Patients with a STEMI admitted to hospitals 
that performed a total of 200 or more PCIs per year were nearly 
seven times as likely to receive same-day PCI compared with simi-
lar patients admitted to low-volume PCI hospitals [32,33]. In addi-
tion, several known advantages of high-volume PCI hospitals like-
ly contributed to cardiac catheterization laboratory availability, 
standard emergency room protocols for the treatment of CHD pa-
tients, and standard catheterization laboratory activation proto-
cols [32].
Although the ACC/AHA clinical practice guidelines recom-
mend a minimum annual hospital PCI case volume of 400, vari-
ous cut-off points were used in the studies. In addition, in our 
study, it was not possible to exactly define a specific minimum 
procedure below which the outcome of CHD patients with PCI 
would be worse than for those patients treated in hospitals meet-
ing this minimum requirement. Therefore, future evaluations of 
hospital PCI volume thresholds will be needed to assess recent and 
pending changes in PCI technology and practice. Given this evi-
dence, there is a need for better strategic approaches from clinical 
and health policy standpoints for the treatment of CHD patients 
with PCI. These strategies should be based not only on establish-
ing a recommended volume of primary PCI procedures, but also 
on developing protocols regarding patient safety. These improve-
ments will result in improved care of CHD patients with PCI.
One strength of our study was that the participants in the sur-
vey may be representative of the overall population. Indeed, our 
large and longitudinal sample allowed the results to be generalized 
to the adult South Korean population. Nevertheless, several limi-
tations that may have affected our results need to be considered in 
the interpretation of our findings. First, selection of patients for 
our study relied on ICD coding of principal diagnosis. Variability 
in coding practices among individuals and institutions may have 
influenced our results. It is difficult to validate individual ICD 
codes because our data is a de-identified database, making it sus-
ceptible to errors related to coding. Second, as this is a large and 
longitudinal nationwide sample, there may be significant hetero-
geneity in the care provided both in the field and at receiving hos-
pitals. We cannot comment on which aspects of patient care most 
affected survival.
In conclusion, the PCI is a procedure that delivers excellent re-
sults, and is employed more and more each year. The present study 
provides evidence that in Korea, CHD patients treated with pri-
mary PCI in high-volume hospitals exhibit lower mortality than 
those treated at low-volume hospitals, as reported in many studies. 
In addition, patients admitted through an emergency room and 
diagnosed with angina pectoris in a hospital with a relatively lower 
annual PCI volume had higher mortality rates. An improved un-
derstanding of the contribution of emergency department care 
may be useful in advancing our understanding of how best to or-
ganize a system of care to ensure optimal outcomes for CHD pa-
tients with PCI.
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